Genetics of arterial hypertension and hypotension

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 374, Issue 5-6, 2007, Pages 429-469

  Rosskopf, Dieter ^a   Schürks, Markus ^b   Rimmbach, Christian ^a   Schäfers, Rafael ^c  

^a UNIVERSITY OF GREIFSWALD   (Germany)

^b UNIVERSITY HOSPITAL ESSEN   (Germany)

^c Evangelisches/Johanniter Klinikum   (Germany)

Author keywords

Genetics; Hypertension; Pharmacogenetics; Salt and volume homoiostasis; Signal transduction; Stroke

Indexed keywords

ADDUCIN; ALDOSTERONE ANTAGONIST; AMILORIDE; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN RECEPTOR ANTAGONIST; ANGIOTENSINOGEN; ATENOLOL; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE; DIURETIC AGENT; G PROTEIN COUPLED RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; HYDROCHLOROTHIAZIDE; METOPROLOL; MINERALOCORTICOID RECEPTOR; PREDNISONE; PROTEIN KINASE; PROTEIN KINASE WNK1; REGULATOR PROTEIN; RHO KINASE; SODIUM CHANNEL; SODIUM CHLORIDE; THIAZIDE DIURETIC AGENT; TRIAMTERENE;

APPARENT MINERALOCORTICOID EXCESS SYNDROME; BLOOD PRESSURE REGULATION; BLOOD PRESSURE VARIABILITY; DNA POLYMORPHISM; GENE MUTATION; GENETIC ANALYSIS; GENETIC VARIABILITY; GENETICS; GORDON SYNDROME; HUMAN; HYPERALDOSTERONISM; HYPERTENSION; HYPOTENSION; ION TRANSPORT; LIDDLE SYNDROME; NONHUMAN; PREDICTOR VARIABLE; PREGNANCY; PSEUDOHYPOALDOSTERONISM; REVIEW; RISK; SIGNAL TRANSDUCTION; SODIUM TRANSPORT; STROKE; UNSPECIFIED SIDE EFFECT;

ALDOSTERONE; BLOOD PRESSURE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; HYDROCORTISONE; HYPERTENSION; HYPOTENSION; MODELS, BIOLOGICAL; PHARMACOGENETICS; RECEPTORS, MINERALOCORTICOID;

EID: 33846850056     PISSN: 00281298     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00210-007-0133-2     Document Type: Review

References (298)

1. Abe M, Nakura J, Yamamoto M, Jin JJ, Wu Z, Tabra Y, Yamamoto Y, Igase M, Kohara K, Miki T (2002) Association of GNAS1 gene variant with hypertension depending on smoking status. Hypertension 40:261-265
2. Agarwal A, Williams GH, Fisher ND (2005) Genetics of human hypertension. Trends Endocrinol Metab 16:127-133
3. Agerholm-Larsen B, Nordestgaard BG, Tybjaerg-Hansen A (2000) ACE gene polymorphisms in cardiovascular disease: meta-analysis of small and large studies in whites. Arterioscler Thromb Vasc Biol 20:484-492
4. Allayee H, Dominguez KM, Aouizerat BE, Krauss RM, Rotter JI, Lu J, Cantor RM, de Bruin TW, Lusis AJ (2001) Genome scan for blood pressure in Dutch dyslipidemic families reveals linkage to a locus on chromosome 4p. Hypertension 38:773-778
5. Anonymous (1999) Freely associating. Nat Genet 22:1-2
6. Aperia AC (2000) Intrarenal dopamine: a key signal in the interactive regulation of sodium metabolism. Annu Rev Physiol 62:621-647
7. Ariza JL, Weinberger C, Cerelli G, Glaser TM, Handelin BL, Housman DE, Evans RM (1987) Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor. Science 237:268-275
8. Armor M, Parker KL, Globerman H, New MI, White PC (1988) Mutation in the CYP21B gene (ile 172 to asn) causes steroid-21-hydroxylase deficiency. Proc Natl Acad Sci USA 85:1600-1604
9. Baker EH, Dong YB, Sagnella GA, Rothwell M, Onipinla AK, Markandu ND, Cappuccio FP, Cook DG, Persu A, Corvol P, Jeunemaitre X, Carter ND, MacGregor GA (1998) Association of hypertension with T594M mutation in the beta subunit of epithelial sodium channels in black people resident in London. Lancet 351:1388-1392
10. Bähring S, Nagai T, Toka HR, Nitz I, Toka O, Aydin A, Muhl A, Wienker TF, Schuster H, Luft FC (1997) Deletion at 12p in a Japanese child with brachydactyly overlaps the assigned locus of brachydactyly with hypertension in a Turkish family. Am J Hum Genet 60:732-735
11. Bähring S, Rauch A, Toka O, Schroeder C, Hesse C, Siedler H, Fesüs G, Haefeli WE, Busjahn A, Aydin A, Neuenfeld Y, Mühl A, Toka HR, Gollasch M, Jordan J, Luft FC (2004) Autosomal-dominant hypertension type E brachydactyly is caused by rearrangement on the short arm of chromosome 12. Hypertension 43:471-476
12. Bengra C, Mifflin TE, Khripin Y, Manunta P, Williams SM, Jose PA, Felder RA (2002) Genotyping essential hypertension SNPs using a homogenous PCR method with universal energy transfer primers. Clin Chem 48:2131-2140
13. Bengtsson K, Melander O, Orho-Melander M, Lindblad U, Ranstam J, Ranstam L, Groop L (2001a) Polymorphisms in the β1-adrenergic receptor gene and hypertension. Circulation 104:187-190
14. Bengtsson K, Orho-Melander M, Melander U, Lindblad U, Ranstam J, Ranstam L, Groop L (2001b) Beta(2) adrenergic receptor gene variation and hypertension in subjects with type 2 diabetes. Hypertension 37:1303-1308
15. Benjafield AV, Jeyasingam CL, Nyholt DR, Griffiths LR, Morris BJ (1998) G-protein beta3 subunit gene (GNB3) variant in causation of essential hypertension. Hypertension 32:1094-1097
16. Bernstein LS, Ramineni S, Hague C, Cladman W, Chidiac P, Levey AI, Hepler JR (2004) RGS2 binds directly and selectively to the M1 muscarinic acetylcholine receptor third intracellular loop to modulate Gq/11alpha signaling. J Biol Chem 279:21248-21256
17. Bernstein KE, Xiao HD, Frenzel K, Li P, Shen XZ, Adams JW, Fuchs S (2005) Six truisms concerning ACE and the renin-angiotensin-system educed from the genetic analysis of mice. Circ Res 96:1135-1144
18. Bettinelli A, Bianchetti MG, Giardin E, Caringella A, Cecconi M, Appiani AC, Ravanello L, Gastaldi R, Isimbaldi C, Lama G (1992) Use of calcium excretion values to distinguish two forms of primari renal tubular hypokalemic alkalosis: Bartter and Gitelmans syndromes. J Pediatr 120:38-43
19. Bianchi G, Tripodi MG, Casari G, Salardi S, Barber BR, Garcia R, Leoni P, Torielli L, Cusi D, Ferrandi M, Pinna LA, Baralle FE, Ferrari P (1994) Two point mutations within the adducin genes are involved in blood pressure variation. Proc Natl Acad Sci USA 91:3999-4003
20. Bianchi G, Ferrari P, Staessen JA (2005) Adducin polymorphism. Detection and impact on hypertension and related disorders. Hypertension 45:331-340
21. Bilginturan N, Zileli S, Karacadag S, Pirnar T (1973) Hereditary brachydactyly with hypertension. J Med Genet 10:253-259
22. Bindels RJM (2003) A molecular switch controlling renal sodium and potassium excretion. Nat Genet 35:302-303
23. Birkenhager R, Otto E, Schurmann MJ, Vollmer M, Rufe EM, Maier-Lutz I, Beekmann F, Fekete A, Imran H, Feldmann D, Milford DV, Jeck N, Konrad M, Landau D, Knoers NVAM, Antignac C, Sudbrak R, Kispert A, Hildebrandt F (2001) Mutations of BSND causes Bartter syndrome with sensorineural deafness and kidney failure. Nature Genet 29:310-314
24. Biron P, Mongeau JG, Bertrand D (1976) Familial aggregation of blood pressure in 558 adopted children. Can Med Assoc J 115:773-774
25. Bis JC, Smith NL, Psaty BM, Heckbert SR, Edwards KL, Lemaitre RN, Lumley T, Rosendaal FR (2003) Angiotensinogen Met235Thr polymorphism, angiotensin-covnerting enzyme inhibition therapy, and the risk for nonfatal stroke or myocardial infarction in hypertension patients. Am J Hypertens 16:1011-1017
26. Bloem LJ, Manantunga AK, Pratt JH (1996) Racial differences in the relationship of an angiotensin-I-converting enzyme gene polymorphism to serum angiontensin I-converting enzyme activity. Hypertension 27:62-66
27. Bongiovanni AM, Root AW (1963) The adrenogenital syndrome. N Engl J Med 268:1283-1289; 1342-1351; 1391-1399
28. Bonnardeaux A, Davies E, Jeunemaitre X, Fery I, Charru A, Clauser E, Tiret L, Cambien F, Corvol P, Soubrier F (1994) Angiotensin II type I receptor gene polymorphisms in human essential hypertension. Hypertension 24:63-69
29. Botero-Velez M, Curtis JJ, Warnock DG (1994) Liddle's syndrome revisited-a disorder of sodium reabsorption in the distal tubule. N Engl J Med 330:178-181
30. Brand E, Herrmann SM, Nicaud V, Ruidavets JB, Evans A, Arveiler D, Luc G, Plouin PF, Tiret L, Cambien F (1999) The 825C/T polymorphism of the G-protein subunit β3 is not related to hypertension. Hypertension 33:1175-1178
31. Brand E, Chatelain N, Paillard F, Tiret L, Visvikis S, Lathrop M, Soubrier F, Demenais F (2002) Detection of putative functional angiotensinogen (AGT) gene variants controlling plasma AGT levels by combined segregation-linkage analysis. Eur J Hum Genet 10:715-723
32. Brand E, Wang JG, Herrmann SM, Staessen JA (2003) An epidemiological study of blood pressure and metabolic phenotypes in relation to the Gbeta3 C825T polymorphism. J Hypertens 21:729-737
33. Bray MS, Krushkal J, Li L, Ferrell R, Kardia S, Sing CF, Turner ST, Boerwinkle E (2000) Positional genomic analysis identifies the beta(2) adrenergic receptor gene as a susceptibility locus for human hypertension. Circulation 101:2877-2882
34. 1- adrenoceptor polymorphism in humans. Pharmacogenetics 11:199-205
35. Busjahn A, Li GH, Faulhaber HD, Rosenthal M, Becker A, Jeschke E, Schuster H, Timmermann B, Hoehe MR, Luft FC (2000) Beta-2 adrenergic recptor gene variations, blood pressure, and heart size in normal twins. Hypertension 35:555-560
36. Cambien F, Poirier O, Lecerf L, Evans A, Cambou JP, Arveiler D, Luc G, Bard JM, Bara L, Ricard S (1992) Deletion polymorphism in the gene for angiotensin-converting enzyme is a potent risk factor for myocardial infarction. Nature 359:641-644
37. Castellano M, Glorioso N, Cusi D, Sarzani R, Fabris B, Opocher G, Zoccali C, Golin R, Veglio F, Volpe M, Mantero F, Fallo F, Rossi GP, Barlassina C, Tizzoni L, Filigheddu F, Giacche M, Rossi F (2003) Genetic polymorphisms of the renin-angiotensin-aldosterone system and arterial hypertension in the Italian population: the GENIPER project. J Hypertens 21:1853-1860
38. Caulfield M, Lavender P, Farrall M, Munroe P, Lawson M, Turner P, Clark AJ (1994) Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 330:1629-1633
39. Caulfield M, Lavender P, Newell-Price J, Farrall M, Kamdar S, Daniel H, Lawson M, De Freitas P, Fogarty P, Clark AJ (1995) Linkage of the angiotensinogen gene locus to human essential hypertension in African Caribbeans. J Clin Invest 96:687-692
40. Caulfield M, Munroe P, Pembroke J, Samani N, Dominiczak A, Brown M, Benjamin N, Webster J, Ratcliffe P, O'Shea S, Papp J, Taylor E, Dobson R, Knight J, Newhouse S, Hooper J, Lee W, Brain N, Clayton D, Lathrop GM, Farrall M, Connell J; MRC British Genetics of Hypertension Study (2003) Genome-wide mapping of human loci for essential hypertension. Lancet 361:2118-2123
41. Chang SS, Grunder S, Hanukoglu A, Rosler A, Mathew PM, Hanukoglu I, Schild L, Lu Y, Shimkets RA, Nelson-Williams C, Rossier BC, Lifton RP (1996) Mutations in subunits of epithelial sodium channels cause salt wasting with hyperkalaemic acidosis, pseudohypoaldosteronism type I. Nat Genet 12:248-253
42. Chen Y, Nakura J, Jin JJ, Wu Z, Yamamoto M, Abe M, Tabara Y, Yamamoto Y, Igase M, Bo X, Kohara K, Miki T (2003) Association of the GNAS1 gene variant with hypertension is dependent on alcohol consumption. Hypertens Res 26:439-444
43. +-ATPase α subunit in response of dopamine. Mol Biol Cell 9:1209-1220
44. Chibalin AV, Ogimoto G, Pedemonte CH, Pressley TA, Katz AI, Feraille E, Berggren PO, Bertorello AM (1999) Dopamine-induced endocytosis of Na ,K -ATPase is initiated by phosphorylation of Ser-18 in the rat α-subunit and is responsible for the decreased activity in epithelial cells. J Biol Chem 274:1920-1927
45. Chu SL, Zhu DL, Xiong MM, Wang GL, Zhang WZ, Zhou HF, Shen D, Gao PJ, Zhan YM, Jin L (2002) Linkage analysis of twelve candidate gene loci regulating water and sodium metabolism and membrane ion transport in essential hypertension. Hypertens Res 25:635-639
46. Cruz DN, Simon DB, Nelson-Williams C, Farhi A, Finberg K, Burleson L, Gill JR, Lifton RP (2001) Mutations in the Na-Cl cotransporter reduce blood pressure in humans. Hypertension 37:1458-1464
47. Cusi D, Bianchi G (1996) Renal mechanisms of genetic hypertension: from the molecular level to the intact organism. Kidney Intern 49:1754-1759
48. Cusi D, Barlassina C, Azzani T, Casari G, Citterio L, Devoto M, Glorioso N, Lanzani C, Manunta P, Righetti M, Rivera R, Stella P, Troffa C, Zagato L, Bianchi G (1997) Polymorphisms of α-adducin and salt sensitivity in patients with essential hypertension. Lancet 349:1353-1357
49. Disse-Nicodeme S, Achard JM, Desitter I, Houot AM, Fournier A, Corvol P, Jeunemaitre X (2000) A new locus on chromose 12p13.3 for pseudohypoaldosteronism type II, an autosomal dominant form of hypertension. Am J Hum Genet 67:302-310
50. +-ATPaseα subunit is essential for AP-2 binding and clathrin-dependent endocytosis. J Biol Chem 277:17108-17111
51. Dong Y, Zhu H, Sagnella GA, Carter ND, Cook DG, Cappuccio FP (1999) Association between the C825T polymorphism of the G protein β3-subunit gene and hypertension in blacks. Hypertension 34:1193-1196
52. Dudley C, Keavney B, Casadei B, Conway J, Bird R, Ratcliffe P (1996) Prediction of patient responses to antihypertensive drugs using genetic polymorphisms: investigation of the renin-angiotensin system genes. J Hypertens 17:9-17
53. Eckhart AD, Ozaki T, Teaearai H, Rockman HA, Koch WJ (2002) Vascular-targeted overexpression of G protein-coupled receptor kinase-2 in transgenic mice attenuates beta-adrenergic receptor signaling and increases resting blood pressure. Mol Pharmacol 61:749-758
54. +-ATPase endocytosis. Circ Res 95:1100 -1108
55. Eichelbaum M, Gross AS (1990) The genetic polymorphisms of debrisoquine/sparteine: metabolism-clinical aspects. Pharmacol Ther 46:377-394
56. Erlich PM, Cui J, Chazaro I, Farrer LA, Baldwin CT, Gavras H, DeStefano AL (2003) Genetic variants of WNK4 in whites and African Americans with hypertension. Hypertension 41:1191-1195
57. Feinleib M, Garrison RJ, Fabsitz R, Christian JC, Hrubec Z, Borhani NO, Kannel WB, Rosenman R, Schwartz JT, Wagner JO (1977) The NHLBI twin study of cardiovascular disease risk factors: methodology and summary of results. Am J Epidemiol 106:284-285
58. Felder RA, Sanada H, Xu J, Yu PY, Wang Z, Watanabe H, Asico LD, Wang W, Zheng S, Yamaguchi I, Williams SM, Gainer J, Brown NJ, Hazen-Martin D, Wong LJ, Robillard JE, Carey RM, Eisner GM, Jose PA (2002) G protein-coupled receptor kinase 4 gene variants in human essential hypertension. Proc Natl Acad Sci USA 99:3872-3877
59. Fernandez-Llama P, Poch E, Oriola J, Botey A, Coll E, Darnell A, Rivera F, Revert L (1998) Angiotensin converting enzyme gene I/D polymorphism in essential hypertension and nephroangiocsclerosis. Kidney Int 53:1743-1747
60. Ferrandi M, Salardi S, Tripodi MG, Barassi P, Rivera R, Manunta P, Goldshleger R, Ferrari P, Bianchi G, Karlish S (1999) Evidence for an interaction between adducin and Na,K'ATPase: relation to genetic hypertension. Am J Physiol 277:1338-1349
61. Ferrari P, Bianchi G (1995) Lessons from experimental genetic hypertension. In: Laragh JH, Brenner BM, eds. Hypertension: Pathophysiology, Diagnosis, and Management. 2nd ed. Raven Press, New York, NY, pp 1261-1279
62. Filigheddu F, Reid JE, Troffa C, PinnaParpaglia P, Argiolas G, Testa A, Skolnick M, Glorioso N (2004) Genetic polymorphisms of the beta-adrenergic system: association with essential hypertension and response to beta-blockade. Pharmacogenomics J 4:154-160
63. Fornage M, Amos CI, Kardia S, Sing CF, Turner ST, Boerwinkle E (1998) Variations in the region of the angiotensin-converting enzyme gene influences interindividual differences in blood pressure levels in young white males. Circulation 97:1773-1779
64. Franca LP, Pacheco NA, Correa SA, Han SW, Nakaie CR, Paiva AC, Shimuta SI (2003) Angiotensin II-mediated cellular responses: a role for the 3′-untranslated region of the angiotensin AT1 receptor. Eur J Pharmacol 476:25-30
65. Funder JW, Pearce PT, Smith R, Smith AI (1987) Mineralocorticoid action: target tissue specificity is enzyme, not receptor, mediated. Science 242:583-585
66. Fux R, Morike K, Prohmer AM, Delabar U, Schwab M, Schaeffeler E, Lorenz G, Gleiter CH, Eichelbaum M, Kivisto KT (2005) Impact of CYP2D6 genotype on adverse effects during treatment with metoprolol: a prospective clinical study. Clin Pharmacol Ther 78:378-387
67. Geller DS, Rodriguez-Soriano J, Boado AV, Schifter S, Bayer M, Chang SS, Lifton RP (1998) Mutations in the mineralocorticoid receptor gene cause autosomal-dominant pseudohypoaldosteronism type I. Nat Genet 19:279-281
68. Geller DS, Farhi A, Pinkerton N, Fradley M, Moritz M, Spitzer A, Meinke G, Tsai FT, Sigler PB, Lifton RP (2000) Activating mineralocorticoid mutations in hypertension exacerbated by pregnancy. Science 289:119-123
69. Giner V, Poch E, Bragulat E, Oriola J, Gonzalez D, Coca A, de la Sierra A (2000) Renin-angiotensin system genetic polymorphisms and salt sensitivity in essential hypertension. Hypertension 35:512-517
70. Glorioso N, Manunta P, Filigheddu F, Troffa C, Stella P, Barlassina C, Lombardi C, Soro A, Dettori F, Pinna Parpaglia P, Sciarrone Alibrandi MT, Cusi D, Bianchi G (1999) The role of α-adducin polymorphism in blood pressure and sodium handling regulation may not be excluded by a negative association study. Hypertension 34:649-654
71. Glorioso N, Filigheddu F, Cusi D, Troffa C, Conti M, Natalizio M, Argiolas G, Barlassina C, Bianchi G (2002) Alpha-Adducin 460Trp allele is associated with erythrocyte Na transport rate in North Sardinian primary hypertensives. Hypertension 39:357-362
72. Gong M, Zhang H, Schulz H, Lee YA, Sun K, Bähring S, Luft FC, Nürnberg P, Reis A, Rohde K, Ganten D, Hui R, Hübner N (2003) Genome-wide linkage reveals a locus for human essential (primary) hypertension on chromosome 12p. Hum Mol Genet 12:1273-1277
73. Gordon D, Geddes RA, Pawsey CG, O'Halloran MW (1970) Hypertension and severe hyperkalaemia associated with suppression of renin and aldosterone and completely reversed by dietary sodium restriction. Australas Ann Med 4:287-294
74. Grant SL, Lassegue B, Griendling KK, Ushio-Fukai M, Lyons PR, Alexander RW (2000) Specific regulation of RGS2 messenger RNA by angiotensin II in cultured vascular smooth muscle cells. Mol Pharmacol 57:460-467
75. Gratze G, Fortin J, Labugger R, Binder A, Kotanko P, Timmermann B, Luft FC, Hoehe MR, Skrabal F (1999) Beta-2 adrenergic receptor variants affect resting blood pressure and agonist-induced vasodilation in young adult Caucasians. Hypertension 33:1425-1430
76. Green SA, Cole G, Jacinto M, Inniw M, Liggett SB (1993) A polymorphism of the human beta 2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor. J Biol Chem 268:23116-23121
77. Green SA, Turki J, Innis M, Liggett SB (1994) Amino-terminal polymorphisms of the human beta 2-adrenergic receptor impart distinct agonist-promoted regulatory properties. Biochemistry 33:9414-9419
78. Gu CC, Chang YP, Hunt SC, Schwander K, Arnett D, Djousse L, Heiss G, Oberman A, Lalouel JM, Province M, Chakravarti A, Rao DC (2005) Haplotype association analysis of AGT variants with hypertension-related traits: the HyperGEN study. Hum Hered 60:164-176
79. Hague C, Bernstein LS, Ramineni S, Chen Z, Minneman KP, Hepler JR (2005) Selective inhibition of alpha1A-adrenergic receptor signaling by RGS2 association with the receptor third intracellular loop. J Biol Chem 280:27289 -27295
80. Hahntow IN, Koopmans RP, Michel MC (2006) The beta2-adrenoceptor gene and hypertension: is it the promoter or the coding region or neither? J Hypertens 24:1003-1007
81. Hannson JH, Schild L, Lu Y, Wilson TA, Gautschi I, Shimkets R, Nelson-Williams C, Rossier BC, Lifton RP (1995a) A de novo missense mutation of the beta subunit of the epithelial sodium channel causes hypertension and Liddle syndrome, identifying a proline-rich segment critical for regulation of channel activity. Proc Natl Acad Sci USA 92:11495-11499
82. Hannson JH, Nelson-Williams C, Suzuki H, Schild L, Shimkets R, Canessa CM, Iwasaki T, Rossier B, Lifton RB (1995b) Hypertension caused by a truncated epithelial sodium channel γ subunit: genetic heterogeneity of Liddle syndrome. Nat Genet 11:76-82
83. Hanukoglu (1991) Type 1 pseudohypoaldosteronism includes two clinically and genetically distinct entities with either renal or multiple target organ defects. J Clin Endocrinol Metab 73:936-944
84. Harrap SB, Tzourio C, Cambien F, Poirier O, Raoux S, Chalmers J, Chapman N, Colman S, Leguennec S, MacMahon S, Neal B, Ohkubo T, Woodward M; PROGRESS Collaborative Group (2003) The ACE gene I/D polymorphism is not associated with the blood pressure and cardiovascular benefits of ACE inhibition. Hypertension 42:297-303
85. Hata A, Namikawa C, Sasaki M, Sato K, Nakamura T, Tamura K, Lalouel JM (1994) Angiotensinogen as a risk factor for essential hypertension in Japan. J Clin Invest 93:1285-1287
86. He X, Wang G, Huang W, Ding-Liang Z (2003) Linkage analysis of five candidate genes and essential hypertension in 106 Chinese nuclear families. J Hum Hypertens 17:69-72
87. 1166C polymorphisms on blood pressure in healthy normotensive primary care population: first results of the Hippocrates study. J Hypertens 21:81-86
88. Herrmann SM, Nicaud V, Tiret L, Evans A, Kee F, Ruidavest JB, Arveiler D, Luc G, Morrison C, Hoehe MR, Paul M, Cambien F (2002) Polymorphisms of the beta2 adrenoceptor (ADRB2) gene and essential hypertension: the ECTIM and PEGASE studies. J Hypertens 20:229-235
89. Heximer SP, Watson N, Linder ME, Blumer KJ, Hepler JR (1997) RGS2/G0S8 is a selective inhibitor of Gqalpha function. Proc Natl Acad Sci USA 94:14389-14393
90. Heximer SP, Knutsen RH, Sun X, Kaltenbronn KM, Rhee MH, Peng N, Oliveira-dos-Santos A, Penninger JM, Muslin AJ, Steinberg TH, Wyss JM, Mecham RP, Blumer KJ (2003) Hypertension and prolonged vasoconstrictor signaling in RGS2-deficient mice. J Clin Invest 111:445-452
91. Hilgers KF, Langenfeld MR, Schlaich M, Veelken R, Schmieder RE (1999) 1166 A/C polymorphism of the angiotensin II type 1 receptor gene and the respone to short-term infusion of angiotensin II. Circulation 100:1394-1399
92. Hilgers KF, Delles C, Veelken R, Schmieder RE (2001) Angiotensinogen gene core promoter variants and non-modulating hypertension. Hypertension 38:1250-1254
93. Hingorani AD, Jia H, Stevens PA, Hopper R, Dickerson JE, Brown MJ (1995) Renin-angiotensin system gene polymorphisms influence blood pressure and the response to angiotensin converting enzyme inhibition. J Hypertens 13:1602-1609
94. Hirschhorn JN, Lohmueller K, Byrne E, Hirschhorn KA (2002) A comprehensive review of genetic association studies. Genet Med 4:45-61
95. Hollier JM, Martin DF, Bell DM, Li JL, Chirachanchai MG, Menon DV, Leonard D, Wu X, Cooper RS, McKenzie C, Victor RG, Auchus RJ (2006) Epithelial sodium channel allele T594M is not associated with blood pressure or blood pressure response to amiloride. Hypertension 474:428-433
96. Hsueh WC, Mitchell BD, Schneider JL, Wagner MJ, Bell CJ, Nanthakumar E, Shuldiner AR (2000) QTL influencing blood pressure maps to the region of PPH1 on chromosome 2q31-34 in old order Amish. Circulation 101:2810-2816
97. Humma LM, Puckett BJ, Richardson HE, Terra SG, Andrisin TE, Lejeune BL, Wallace MR, Lewis JF, McNamara M, Picoult-Newberg L, Pepine CJ, Johnson JA (2001) Effects of β-1 AR genetic polymorphisms on resting haemodynamics in patients undergoing diagnostig testing for ischemia. Am J Cardiol 88:1034-1037
98. Iliadou A, Lichtenstein P, Morgenstern R, Forsberg L, Svensson R, de Faire U, Martin NG, Pedersen NL (2002) Repeated blood pressure measurements in a sample of Swedish twins: heritabilities and associations with polymorphisms in the renin-angiotensin-aldosterone system. J Hypertens 20:1543-1550
99. Ingi T, Krumins AM, Chidiac P, Brothers GM, Chung S, Snow BE, Barnes CA, Lanahan AA, Siderovski DP, Ross EM, Gilman AG, Worley PF (1998) Dynamic regulation of RGS2 suggests a novel mechanism in G-protein signaling and neuronal plasticity. J Neurosci 18:7178-7188
100. Inoue I, Nakajima T, Williams CS, Quackenbush J, Puryear R, Powers M, Cheng T, Ludwig EH, Sharma AM, Hata A, Jeunemaitre X, Lalouel JM (1997) A nucleotide substitution in the promoter of human angiotensinogen is associated with essential hypertension and affects basal transcription in vitro. J Clin Invest 99:1786-1797
101. Inoue I, Iwaoka T, Tokunaga H, Takamune K, Naomi S, Araki M, Takahama K, Yamaguchi K, Tomita K (1998) A family with Liddle's syndrome caused by a new missense mutation in the beta subunit of the epithelial sodium channel. J Clin Endocrinol Metab 83:2210-2213
102. Iwai N, Ohmichi N, Nakamura Y, Kinoshita M (1994) DD genotype of the angiotensin-converting enzyme gene is a risk factor for left ventricular hypertrophy. Circulation 90:2622-2628
103. Iwai N, Baba S, Mannami T, Katsuya T, Higaki J, Ogihara T, Ogata J (2001) Association of sodium channel gamma-subunit promoter variant with blood pressure. Hypertension 38:86-89
104. Iwai N, Baba S, Mannami T, Ogihara T, Ogata J (2002) Association of a sodium channel α promoter variant with blood pressure. J Am Soc Neprol 13:80-85
105. Janetta PJ, Segal R, Wolfson SK (1985) Neurogenic hypertension: etiology and surgical treatment. I. Observations in 53 patients. Ann Surg 201:391-398
106. Jeck N, Waldegger S, Lampert A, Boehmer C, Waldegger P, Lang PA, Wissinger B, Friedrich B, Risler T, Moehle R, Lang UE, Zill P, Bondy B, Schaefeler E, Asante-Poku S, Seyberth J, Schwab M, Lang F (2004) Activating mutation of the renal epithelial chloride channel ClC-Kb presdisposing to hypertension. Hypertension 43:1175-1181
107. Jeunemaitre X, Lifton RP, Hunt SC, Williams RR, Lalouel JM (1992a) Absence of linkage between the angiotensin converting enzyme locus and human essential hypertension. Nat Genet 1:72-75
108. Jeunemaitre X, Soubrier F, Kotelevtsev YV, Lifton RP, Williams SC, Charru A, Hunt SC, Hopkins PN, Williams RR, Lalouel JM (1992b) Molecular basis for human hypertension: role of angiotensinogen. Cell 71:169-180
109. Jeunemaitre X, Inoue I, Williams C, Charru A, Tichet J, Powers M, Sharma AM, Gimenez-Roqueplo AP, Hata A, Corvol P, Lalouel JM (1997) Haplotypes of angiotensinogen in essential hypertension. Am J Hum Genet 60:1448-1460
110. Jia H, Hingorani AD, Sharma P, Hopper R, Dickerson C, Trutwein D, Lloyd DD, Brown MJ (1999) Association of the G(s)alpha gene with essential hypertension and response to beta blockade. Hypertension 34:8-14
111. Johnson JA, Zineh I, Puckett BJ, McGorray SP, Yarandi HN, Pauly DF (2003) Beta1-adrenergic receptor polymorphisms and antihypertensive response to metoprolol. Clin Pharmacol Ther 74:372-379
112. Jordan J, Toka HR, Heusser K, Toka O, Shannon JR, Tank J, Diedrich A, Stabroth C, Stoffels M, Naraghi R, Oelkers W, Schuster H, Schobel HP, Haller H, Luft FC (2000) Severely impaired baroreflex buffering in patients with monogenic hypertension and neurovascular contact. Circulation 102:2611-2618
113. Ju Z, Zhang H, Sun K, Song Y, Lu H, Hui R, Huang X (2003) Alpha-adducin gene polymorphism is associated with essential hypertension in Chinese: a case-control and family-based study. J Hypertens 21:1861-1868
114. Kagimoto M, Winter JSD, Kagimoto K, Simpson ER, Waterman MR (1988) Structural characterization of normal and mutant human steroid 17-α-hydrocylase genes: molecular basis of one example of combined 17-α-hydroxylase/ 17, 20 lyase deficiency. Mol Endocr 2:564-570
115. Kainulainen K, Perola M, Terwilliger J, Kaprio J, Koskenvuo M, Syvanen AC, Vartiainen E, Peltonen L, Kontula K (1999) Evidence for involvement of the type 1 angiotensin II receptor locus in essential hypertension. Hypertension 33:844-849
116. Kamide K, Takiuchi S, Tanaka C, Miwa Y, Yoshii M, Horio T, Mannami T, Kokubo Y, Tomoike H, Kawano Y, Miyata T (2004) Three novel missense mutations of WNK4, a kinase mutated in inherited hypertension, in Japanese hypertensives: implication of clinical phenotypes. Am J Hypertens 17:446-449
117. Kammerer CM, Gouin N, Samollow PB, Vandeberg JF, Hixson JE, Cole SA, MacCluer JW, Atwood LD (2004) Two quantiative trait loci affect ACE activities in Mexican-Americans. Hypertension 25:1266-1269
118. + channel. FASEB J 15:204-214
119. Kario K, Hoshide S, Umeda Y, Sato Y, Ikeda U, Nishiuma S, Matsuo M, Shimada K (1999) Angiotensinogen and angiotensin-converting enzyme genotypes, and day and night blood pressures in elderly Japanese hypertensives. Hypertens Res 22:95-103
120. Karlsson J, Lind L, Hallberg P, Michaelsson K, Kurland L, Kahan T, Malmqvist K, Ohman KP, Nystrom F, Melhus H (2004) Beta1-adrenergic receptor gene polymorphisms and response to beta 1-adrenergic receptor blockade in patients with essential hypertension. Clin Cardiol 27:347-350
121. Kato N, Sugiyama T, Morita H, Kurihara H, Yamori Y, Yazaki Y (1999) Angiotensinogen gene and essential hypertension in the Japanese: extensive association study and meta-analysis on six reported studies. J Hypertens 17:757-763
122. Kato N, Sugiyama T, Morita H, Kurihara H, Sato T, Yamori Y, Yazaki Y (2001) Association analysis of beta(2) adrenergic receptor polymorphisms with hypertension in Japanese. Hypertension 37:286-292
123. Keavney B, McKenzie C, Parish S, Palmer A, Clark S, Youngman L, Delephine M, Lathrop M, Peto R, Collins R (2000) Large-scale test of hypothessised associations between the angiotensin-converting enzyme insertion / deletion polymorphism and myocardial infarction in about 5000 cases and 6000 controls. International Studies of Infarct Survival (ISIS) Collaborators. Lancet 355:434-442
124. i-mediated signaling. Circulation 112:1145-1153
125. Kirchhausen T (2000) Three ways to make a vesicle. Nat Rev Mol Cell Biol 3:187-198
126. Kobashi G, Hata A, Ohta K, Yamada H, Kato EH, Minakami H, Fujimoto S, Kondo K (2004) A1166C variant of angiotensin II type 1 receptor gene is associated with severe hypertension in pregnancy independently of T235 variant of angiotensinogen gene. J Human Genet 49:182-186
127. Kokubo Y, Iwai N, Tago N, Inamoto N, Okayama A, Yamawaki H, Naraba H, Tomoike H (2005) Association analysis between hypertension and CYBA, CLCNKB, and KCNMB1 functional polymorphisms in the Japanese population-the Suita Study. Circ J 69:138-142
128. Koopmans RP, Insel PA, Michel MC (2003) Pharmacogenetics of hypertension treatment: a structured review. Pharmacogenetics 13:705-713
129. Kotanko P, Binder A, Tasker J, DeFreitas P, Kamdar S, Clark AJ, Skrabal F, Caulfield M (1997) Essential hypertension in African Caribbeans associates with a variant of the beta2-adrenoceptor. Hypertension 30:773-776
130. Kunz R, Kreutz R, Beige J, Distler A, Sharma AM (1997) Association between the angiotensinogen 235T variant and essential hypertension in whites: a systematic review and methodological appraisal. Hypertension 30:1331-1337
131. Kurland L, Melhus H, Karlsson J, Kahan T, Malmqvist K, Ohman KP, Nystrom F, Hagg A, Lind L; Swedish Irbesartan Left Ventricular Hypertrophy Investigation versus Atenolol (SILVHIA) Trial (2001) Angiotensin converting enzyme gene polymorphism predicts blood pressure responses to angiotensin II receptor type I antagonist treatment in hypertensive patients. J Hypertens 19:1783-1787
132. Kurland L, Liljedahl U, Karlsson J, Kahan T, Malmqvist K, Melhus H, Syvanen AC, Lind LL (2004) Angiotensinogen gene polymorphisms: relationship to blood pressure response to antihypertensive treatment. Results from the Swedish Irbesartan Left Ventricular Hypertrophy Investigation vs Atenolol (SILVHIA) trial. Am J Hypertens 17:8-13
133. Lajemi M, Labat C, Gautier S, Lacolley P, Safar M, Asmar R, Cambien F, Benetos A (2001) Angiotensin II type 1 receptor-153A/G and 1166A/C gene polymorphisms and increase in aortic stiffness with age in hypertensive subjects.. J Hypertens 19:407-413
134. Lalioti MD, Zhang J, Volkman HM, Kahle KT, Hoffmann KE, Toka HR, Nelson-Williams C, Ellison D, Flavell R, Booth CJ, Lu Y, Geller DS, Lifton RP (2006) Wnk4 controls blood pressure and potassium homeostasis via regulation of mass and activity of the distal convoluted tubule. Nat Genet 38:1124-1132
135. Leineweber K, Büscher R, Bruck H, Brodde OE (2004) β-adrenoceptor polymorphisms. Naunyn-Schmiedebergs Arch Pharmacol 369:1-22
136. Levy D, DeStefano AL, Larson MG, O'Donnell CJ, Lifton RP, Gavras H, Cupples LA, Myers RH (2000) Evidence for a gene influencing blood pressure on
137. Li A, Li KX, Marui S, Krozowski ZS, Batista MC, Whorwood CB, Arnhold IJ, Shackleton CH, Mendoca BB, Stewart PM (1997) Apparent mineralocorticoid excess in a Brazilian kindred. Hypertension in the heterozygous state. J Hypertens 15:1397-1402
138. Liddle GW, Bledsoe T, Coppage WS (1963) A familial renal disorder simulating primary aldosteronism but with negligible aldosterone secretion. Trans Am Assoc Physicians 76:199-213
139. Lifton RP, Dluhy RG, Powers M, Rich GM, Cook S, Ulick S, Lalouel JM (1992a) A chimaeric 11 β-hydroxylase/aldosterone synthase gene causes glucocorticoid-remediable aldosteronism and human hypertension. Nature 355:262-265
140. Lifton RP, Dluhy RG, Powers M, Rich GM, Gutkin M, Fallo F, Gill JR Jr, Feld L, Ganguly A, Laidlaw JC (1992b) Hereditary hypertension caused by chimaeric gene duplications and ectopic expression of aldosterone synthase. Nat Genet 2:66-74
141. Lin MH, Tseng CH, Tseng CC, Huang CH, Chong CK, Tseng CP (2001) Real-time PCR for rapid genotyping of angiotensin-converting enzyme insertion/deletion polymorphism. Clin Biochem 34:661-666
142. Litchfield WR, Anderson BF, Weiss RJ, Lifton RP, Dluhy RG (1998) Intracranial aneurysms and hemorrhagic stroke in glucocorticoid-remediable aldosteronism. Hypertension 31:445-450
143. Liu J, Liu ZQ, Tan ZR, Chen XP, Wang LS, Zhou G, Zhou HH (2003) Gly389Arg polymorphism of β1-adrenergic receptor is associated with the cardiovascular response to metoprolol. Clin Pharmacol Ther 74:372-379
144. Liu S, Premont RT, Kontos CD, Zho S, Rockey DC (2005) A crucial role for GRK2 in regulatin of endothelial cell nitric oxide synthase function in portal hypertension. Nat Med 11:952-958
145. Liu J, Liu ZQ, Yu BN, Xu FH, Mo W, Zhou G, Liu YZ, Li Q, Zhou HH (2006) Beta1-Adrenergic receptor polymorphisms influence the response to metoprolol monotherapy in patients with essential hypertension. Clin Pharm Ther 80:23-32
146. Longini IM, Higgins MW, Hinton PC, Moll PC, Keller JB (1984) Environmental and genetic sources of familial aggregation of blood pressure in Tecumseh, Michigan. Am J Epidemiol 120:131-144
147. Maeda Y, Ikeda U, Ebata H, Hojo Y, Seino Y, Hayashi Y, Kuroki S, Shimada K (1996) Angiotensin-converting enzyme gene polymorphisms in hypertensive individuals with parental history of stroke. Stroke 27:1521-1523
148. Mansfield TA, Simon DB, Farfel Z, Bia M, Tucci JR, Lebel M, Gutkin M, Vialettes B, Christofilis MA, Kauppinen-Makelin R, Mayan H, Risch N, Lifton RP (1997) Multilocus linkage of familial hyperkalemia and hypertension, pseudohypoaldosteronism type II, to chromosomes 1q31-42 and 17p11-q21. Nat Genet 16:202-205
149. Mason DA, Moore JD, Green SA, Liggett SB (1999) A gain-offunction polymorphism in a G-protein coupling domain of the human beta 1-adrenergic receptor. J Biol Chem 274:12670-12674
150. Matsuoka Y, Li X, Bennett V (2000) Adducin: structure, function and regulation. Cell Mol Life Sci 57:884-895
151. McGraw DW, Forbes SL, Kramer LA, Ligett SB (1998) Polymorphisms of the 5′ leader cistron of the human beta2-adrenergic receptor regulate receptor expression. J Clin Invest 102:1927-1932
152. McKenzie CA, Sinsheimer JS, Adeyemo AA, Cox RD, Southam L, Hugill A, Bouzekri N, Lathrop M, Forrester TE, Cooper RS, Ward R (2005) SNP haplotypes in the angiotensin I-converting enzyme (ACE) gene analysis of Nigerian family data using gamete competition models. Ann Hum Genet 69:227-232
153. Mellen PB, Herrington DM (2005) Pharmacogenomics of blood pressure response to antihypertensive treatment. J Hypertens 25:1311-1325
154. Mitchell A, Buhrmann S, Seifert A, Nüurnberger J, Wenzel RR, Siffert W, Philipp T, Schäfers RF (2003) Venous response to nitroglycerin is enhanced in young, healthy carriers of the 825T allele of the G protein beta3 subunit gene (GNB3). Clin Pharmacol Ther 74:499-504
155. Mitchell A, Luckebergfeld B, Buhrmann S, Rushentsova U, Nürnberger J, Siffert W, Schäfers RF, Philipp T, Wenzel RR (2004) Effects of systemic endothelin A receptor antagonism in various vascular beds in men: in vivo interactions of the major blood pressure-regulating systems and associations with the GNB3 C825T polymorphism. Clin Pharmacol Ther 76:396-408
156. Mitchell A, Pace M, Nürnberger J, Wenzel RR, Siffert W, Philipp T, Schäfers RF (2005) Insulin-mediated venodilation is impaired in young, healthy carriers of the 825T allele of the G-protein beta3 subunit gene (GNB3). Clin Pharmacol Ther 77:495-502
157. Mitsuuchi Y, Kawamoto T, Rosier A, Naiki Y, Miyahara K, Toda K, Kuribayashi I, Orii T, Yasuda K, Miura K, Nakao K (1992) Congenitally defective aldosterone biosynthesis in humans: the involvement of point mutations of the P-450(C18) gene (CYP11B2) in CMO II deficient patients. Biochem Biophys Res Commun 182:974-979
158. Mondorf UF, Russ A, Wiesemann A, Herrero M, Oremek G, Lenz T (1998) Contribution of angiotensin I converting enzyme gene polymorphisms and angiotensinogen polymorphisms to blood pressure regulation in essential hypertension. Am J Hypertens 11:174-183
159. Morgan T, Craven C, Nelson L, Lalouel JM, Ward K (1997) Angiotensinogen T235 expression is elevated in decidual spiral arteries. J Clin Invest 100:1406-1415
160. Morgan L, Crawshaw S, Baker PN, Pipkin FB, Kalsheker N (2000) Polymorphism in oestrogen response element associated with variation in plasma angiotensinogen concentrations in healthy pregnant women. J Hypertens 18:553-557
161. Morrison AC, Doris PA, Folsom AR, Nieto FJ, Boerwinkle E; Atherosclerosis Risk in Communities Study (2001) G-protein β3 subunit and α-adducin polymorphisms and risk of subclinical and clinical stroke. Stroke 32:822-829
162. Mune T, Roberson FM, Nikkiä H, Agarwal AK, White PC (1995) Human hypertension caused by mutations in the kidney isozyme of 11β- hydroxysteroid dehydrogenase. Nat Genet 10:394-399
163. Nagy Z, Busjahn A, Bähring S, Faulhaber HD, Gohlke HR, Knoblauch H, Rosenthal M, Müller-Myhsok B, Schuster H, Luft FC (1999) Quantitative trait loci for blood pressure exist near the IGF-1, the Liddle syndrome, the angiotensin II receptor gene and the renin loci in man. J Am Soc Nephrol 10:1709-1716
164. Nakai K, Itoh C, Miura Y, Hotta K, Musha T, Itoh T, Miyakawa T, Iwasaki R, Hiramori K (1994) Deletion polymorphism of the angiotensin-I-converting enzyme gene is associated with serum ACE concentrations and increased risk for CAD in the Japanese. Circulation 90:2199-2202
165. Nakajima T, Jorde LB, Ishigama T, Umemura S, Emi M, Lalouel JM, Inoue I (2002) Nucleotide diversity and haplotype structure of the human angiotensinogen gene in two populations. Am J Hum Genet 70:108-123
166. Nakano Y, Oshima T, Watanabe M, Matsuura H, Kajiyama G, Kambe M (1997) Angiotensin-I converting enzyme gene polymorphism and acute responses to captopril in essential hypertension. Am J Hypertens 10:1064-1068
167. Nalogowska-Glosnicka K, Lacka BI, Zychma MJ, Grzeszczak W, Zukowska-Szczechowska E, Poreba R, Michalski B, Kniazewski B, Rzempoluch J; PIH Study Group (2000) Angiotensin II type 1 receptor gene A1166C polymorphism associated with the increased risk of pregnancy-induced hypertension. Med Sci Monitor 6:523-529
168. Naraghi R, Geiger H, Crnac J, Huk W, Fahlbusch R, Engels G, Luft FC (1994) Posterior fossa neurovascular abnormalities in essential hypertension. Lancet 344:1466-1470
169. Naraghi R, Schuster H, Toka HR, Bähring S, Toka O, Oztekin O, Bilginturan N, Knoblauch H, Wienker TF, Busjahn A, Haller H, Fahlbusch R, Luft FC (1997) Neurovascular compression at the ventrolateral medulla in autosomal dominant hypertension and brachydactyly. Stroke 28:1749-1754
170. New MI, Levine LS, Biglieri EG, Pareira J, Ulick S (1977) Evidence for an unidentified steroid in a child with apparent mineralocorticoid hypertension. J Clin Endocrinol Metab 44:924-933
171. Newhouse SJ, Wallace C, Dobson R, Mein C, Pembroke J, Farrall M, Clayton D, Brown M, Samani N, Dominiczak A, Connell JM, Webster J, Lathrop GM, Caulfield M, Munroe PB (2005) Haplotypes of the WNK1 gene associate with blood pressure variation in a severely hypertensive population from the British Genetics of Hypertension study. Hum Mol Genet 14:1805-1814
172. Ng DP, Tai BC, Koh D, Tan KW, Chia KS (2005) Angiotensin-I-converting enzyme insertion/deletion polymorphism and its association with diabetic nephropathy: a meta analysis of studies reported between 1994 and 2004 and comprising 14,727 subjects. Diabetologia 54:1238-1244
173. Nickenig G, Michaelsen F, Müller C, Vogel T, Strehlow K, Böhm M (2001) Post-transcriptional regulation of the AT1 receptor mRNA. Identification of the mRNA binding motif and functional characterization. FASEB J 15:1490-1492
174. Nickenig G, Michaelsen F, Muller C, Berger A, Vogel T, Sachinidis A, Vetter H, Böhm M (2002) Destabilization of AT1 receptor mRNA by calreticulin. Circ Res 90:53-58
175. Niu T, Xu X, Cordell HJ, Rogus J, Zhou Y, Fang Z, Lindpaintner K (1999) Linkage analysis of candidate genes and gene-gene interactions in Chinese hypertensive sib pairs. Hypertension 33:1332-1337
176. Nkeh B, Samani NJ, Badenhorst D, Libhaber E, Sareli P, Norton GR, Woodiwiss AJ (2003) T594M variant of the epithelial sodium channel beta-subunit gene and hypertension in individuals of African ancestry in South Africa. Am J Hypertens 16:847-852
177. Nürnberger J, Dammer S, Mitchell A, Siffert W, Wenzel RR, Gossl M, Philipp T, Michel MC, Schäfers RF (2003) Effect of the C825T polymorphism of the G protein beta 3 subunit on the systolic blood pressure-lowering effect of clonidine in young, healthy male subjects. Clin Pharmacol Ther 74:53-60
178. Nürnberger J, Opazo Saez A, Mitchell A, Buhrmann S, Wenzel RR, Siffert W, Philipp T, Schäfers RF (2004) The T-allele of the C825T polymorphism is associated with higher arterial stiffness in young healthy males. J Hum Hypertens 18:267-271
179. O'Donnel CJ, Lindpaintner K, Larson MG, Rao VS, Ordovas JM, Schaefer EJ, Myers RH, Levy D (1998) Evidence for association and genetic linkage of the angiotensinogen-converting enzyme locus with hypertension and blood pressure in men but not in women of the Framingham Heart Study. Circulation 97:1766-1772
180. +-ATPase activity and endocytosis by modulating the recruitment of adaptor protein 2 and clathrin. Proc Natl Acad Sci USA 97:3242-3247
181. Ohmichi N, Iwai N, Uchida Y, Shichiri G, Nakamura Y, Kinoshita M (1997) Relationship between the response to angiotensin-converting enzyme inhibitor imidapril and the angiotensin converting enzyme genotype. Am J Hypertens 10:951-955
182. Ono K, Mannami T, Baba S, Yasui N, Ogihara T, Iwai N (2003) Lack of association between angiotensin II typ I receptor gene polymorphism and essential hypertension in Japanese. Hypertens Res 26:131-134
183. O'Shaughnessy KM, Fu B, Dickerson C, Thurston D, Brown MJ (2000) The gain-of-function G389R variant of the beta 1-adrenoceptor does not influence blood pressure or heart rate response to beta-blockade in hypertensive subjects. Clin Sci 99:233-238
184. Palmer BF, Alpern RJ (1998) Liddle's syndrome. Am J Med 104:301-309
185. Pascoe L, Curnow KM, Slutsker L, Connell JM, Speiser PW, New MI, White PC (1992a) Glucocorticoid-suppressible hyperaldosteronism results from hybrid genes created by unequal cross-overs between CYP11B1 and CYP11B2. Proc Natl Acad Sci USA 89:8327-8331
186. Pascoe L, Curnow KM, Slutsker L, Rosier A, White PC (1992b) Mutations in the human CYP11B2 (aldosterone synthase) gene causing corticosterone methyloxidase II deficiency. Proc Natl Acad Sci USA 89:4996-5000
187. Peng JB, Bell PD (2006) Cellular mechanisms of WNK4-mediated regulation of ion transport proteins in the distal tubule. Kidney Int 69:2116-2118
188. + channel in essential hypertension. J Hypertens 17:639-645
189. Poch E, Gonzalez D, Gomez-Angelats E, Enjuto M, Pare JC, Rivera F, de La Sierra A (2000) G-Protein β3 subunit gene variant and left ventricular hypertrophy in essential hypertension. Hypertension 35:214-218
190. Pontremoli R, Sofia A, Tirotta A, Ravera M, Nicolella C, Viazzi F, Bezante GP, Borgia L, Bobola N, Ravazzolo R, Sacchi G, Deferrari G (1996) The deletion polymorphism of the angiotensin I-converting enzyme gene is associated with target organ damage in essential hypertension. J Am Soc Nephrol 7:2550-2558
191. Psaty BM, Smith NL, Heckbert SR, Vos HL, Lemaitre RN, Reiner AP, Siscovick DS, Bis J, Lumley T, Longstreth WT Jr, Rosendaal FR (2002) Diuretic therapy, the alpha-adducin gene variant, and the risk of myocardial infarction or stroke in persons with treated hypertension. J Am Med Assoc 287:1680-1689
192. Ranade K, Jorgensohn EH, Sheu W, Pei D, Hsiung CA, Chiang F, Chen YI, Pratt R, Olshen RA, Curb D, Cox DR, Botstein D, Risch N (2002) A polymorphism in the β1 adrenergic receptor is associated with resting heart rate. Am J Hum Genet 70:935-942
193. Rhatz DA, Brown KM, Kramer LA, Liggett SB (2002) Amino acid 49 polymorphism of the human beta1-adrenergic receptor affect agonist-promoted trafficking. J Cardiovasc Pharmacol 39:155-160
194. Rice T, Vogler GP, Perusse L, Bouchard C, Rao DC (1989) Cardiovascular risk factors in a French Canadian population: resolution of genetic and familial environmental effects on blood pressure using twin, adoptees, and extensive information on environmental correlates. Genet Epidemiol 6:571-588
195. Rich GM, Ulick S, Cook S, Wang JZ, Lifton RP, Dluhy RG (1992) Glucocorticoid-remediable aldosteronism in a large kindred: clinical spectrum and diagnosis using a characteristic biochemical phenotype. Ann Intern Med 15:813-820
196. Riddle EL, Rana BK, Murthy KK, Rao F, Eskin E, O'Connor DT, Insel PA (2006) Polymorphisms and haplotypes of the regulator of G protein signaling-2 gene in normotensives and hypertensives. Hypertension 47:415-420
197. Riento K, Ridley AJ (2003) Rocks: multifunctional kinases in cell behaviour. Nat Rev Mol Cell Biol 4:446-456
198. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F (1990) An insertion/deletion polymorphism in the angiotensin I-converting enzym gene accounting for half the variance of serum enzyme levels. J Clin Invest 86:1343-1346
199. Rosmond R, Ukkola O, Changnon M, Bouchard C, Bjorntorp P (2000) Polymorphisms of the beta2-adrenergic receptor gene (ADRB2) in relation to cardiovascular risk factors in men. J Intern Med 248:239-244
200. Rosskopf D, Frömter E, Siffert W (1993) Hypertensive sodium-proton exchanger phenotype persists in immortalized lymphoblasts from essential hypertensive patients. A cell culture model for human hypertension. J Clin Invest 92:2553-2559
201. Rosskopf D, Busch S, Manthey I, Siffert W (2000) G protein beta 3 gene: structure, promoter, and additional polymorphisms. Hypertension 36:33-41
202. Rosskopf D, Manthey I, Siffert W (2002) Identification and ethnic distribution of major haplotypes in the gene GNB3 encoding the G-protein beta3 subunit. Pharmacogenetics 12:209-220
203. Rosskopf D, Manthey I, Habich C, Kielbik M, Eisenhardt A, Nikula C, Urban M, Kohnen S, Graf E, Ravens U, Siffert W (2003a) Identification and characterization of Gβ3s2, a novel splice variant of the G-protein β3 subunit. Biochem J 371:223-232
204. Rosskopf D, Koch K, Habich C, Geerdes J, Ludwig A, Wilhelms S, Jakobs KH, Siffert W (2003b) Interaction of Gβ3s, a splice variant of the G-protein Gβ3, with Gγ- and Gα-proteins. Cell Signal 15:479-488
205. Ruiz-Velasco V, Ikeda SR (2003) A splice variant of the G protein beta 3-subunit implicated in disease states does not modulate ion channels. Physiol Genomics 13:85-95
206. Salim S, Sinnarajah S, Kehrl JH, Dessauer CW (2003) Identification of RGS2 and type V adenylyl cyclase interaction sites. J Biol Chem 278:15842-15849
207. Sasaki M, Oki T, Iuchi A, Tabata T, Yamada H, Manabe K, Fukuda K, Abe M, Ito S (1996) Relationship between the angiotensin converting enzyme gene polymorphism and the effects of enalapril on left ventricular hypertrophy and impaired diastolic filling in essential hypertension: M-mode and pulsed Doppler echocardiographic studies. J Hypertens 14:1403-1408
208. Sayed-Tabatabaei FA, Oostra BA, Isaacs A, van Duijn CM, Witteman JCM (2006) ACE polymorphisms. Circ Res 98:1123-1133
209. Schild L, Lu Y, Gautschi I, Schneeberger E, Lifton RP, Rossier BC (1995) Identification of a PY motif in the epithelial Na channel subunits as target sequences for mutations causing channel activation found in Liddle syndrome. EMBO J 15:2381-2387
210. Schmidt S, van Hooft IM, Grobbee DE, Ganten D, Ritz E (1993) Polymorphism of the angiotensin I converting enzyme gene is apparently not related to high blood pressure: Dutch Hypertension and Offspring Study. J Hypertens 11:345-348
211. Schmidt S, Beige S, Walla-Friedel M, Michel MC, Sharma AM, Ritz E (1997) A polymorphism in the gene for the angiotensin II type 1 receptor is not associated with hypertension. J Hypertens 15:1385-1388
212. Schunkert H, Hense HW, Holmer SR, Stender M, Perz S, Keil U, Lorell BH, Riegger GA (1994) Association between a deletion polymorphism of the angiotensin-converting-enzyme gene and left ventricular hypertrophy. N Engl J Med 330:1634-1638
213. Schunkert H, Hense HW, Döring A, Riegger GA, Siffert W (1998) Association between a polymorphism in the G protein beta3 subunit gene and lower renin and elevated diastolic blood pressure levels. Hypertension 32:510-513
214. Schuster H, Wienker TF, Toka HR, Bähring S, Jeschke E, Toka O, Busjahn A, Hempel A, Talhammer C, Oelkers W, Kunze J, Bilginturan N, Haller H, Luft FC (1996a) Autosomal dominant hypertension and brachydactyly in a Turkish kindred resembles essential hypertension. Hypertension 28:1085-1092
215. Schuster H, Wienker TE, Bähring S, Bilginturan N, Toka HR, Neitzel H, Jeschke E, Toka O, Gilbert D, Lowe A, Ott J, Haller H, Luft FC (1996b) Severe autosomal dominant hypertension and brachydactyly in a unique Turkish kindred maps to human chromosome 12. Nat Genet 13:98-100
216. Schuster H, Toka O, Toka HR, Busjahn A, Öztekin Ö, Wienker TF, Bilginturan N, Bähring S, Skrabal F, Haller H, Luft FC (1998) A cross-over medication trial for autosomal-dominant hypertension with brachydactytly. Kidney Int 53:167-172
217. Schwartz GL, Turner ST, Chapman AB, Boerwinkle E (2002) Interacting effects of gender and genotype on blood pressure response to hydrochlorothiazide. Kidney Int 62:1718-1723
218. Sciarrone MT, Stella P, Barlassina C, Manunta P, Lanzani C, Bianchi G, Cusi D (2003) ACE and alpha-adducin polymorphism as markers of individual response to diuretic therapy. Hypertension 41:398-403
219. Seasholtz TM, Wessel J, Rao F, Rana BK, Khandrika S, Kennedy BP, Lillie EO, Ziegler MG, Smith DW, Schork NJ, Brown JH, O'Connor DT (2006) Rho kinase polymorphism influences blood pressure and systemic vascular resistance in human twins: role of heredity. Hypertension 47:937-947
220. Sethi AA, Nordestgaard BG, Tybjaerg-Hansen A (2003) Angiotensinogen gene polymorphism, plasma angiotensinogen, and risk of hypertension and ischemic heart diseases. A meta-analysis. Arterioscler Thromb Vasc Biol 23:1269-1275
221. Sharma P (1998) Meta-analysis of the ACE gene in ischemic stroke. J Neurol Neurosurg Psychiatry 64:227-230
222. Shimkets RA, Warnock DG, Bositis CM, Nelson-Williams C, Hanson JH, Schambelan M, Gill JR, Ulick S, Milora RV, Findling JW, Canessa CM, Rossier BC, Lifton RP (1994) Liddle's syndrome. Heritable human hypertension caused by mutations in the β subunit of the epithelial sodium channel. Cell 79:407-414
223. Shimkets RA, Lifton RP, Cannessa CM (1997) The activity of the epithelial sodium channel is regulated by clathrin-mediated endocytosis. J Biol Chem 272:25537-25541
224. Sierra C, Coca A, Gomez-Angelats E, Poch E, Sobrino J, de la Sierra A (2002) Renin-angiotensin system genetic polymorphisms and white cerebral white matter lesions in essential hypertension. Hypertension 39:343-347
225. Siffert W, Rosskopf D, Siffert G, Busch S, Moritz A, Erbel R, Sharma AM, Ritz E, Wichmann HE, Jakobs KH, Horsthemke B (1998) Asociation of a human G-protein beta 3 subunit variant with hypertension. Nat Genet 18:45-48
226. Siffert W, Forster P, Jockel KH, Mvere DA, Brinkmann B, Naber C, Crookes R, Du P, Heyns A, Epplen JT, Fridey J, Freedman BI, Muller N, Stolke D, Sharma AM, Al Moutaery K, Grosse-Wilde H, Buerbaum B, Ehrlich T, Ahmad HR, Horsthemke B, Du Toit ED, Tiilikainen A, Ge J, Wang Y, Rosskopf D (1999) Worldwide ethnic distribution of the G protein β3 subunit 825T allele and its association with obesity in Caucasian, Chinese, and Black African individuals. J Am Soc Nephrol 10:1921-1930
227. Simon DB, Nelson-Williams C, Johnson Bia M, Ellison D, Karet FE, Molina AM, Vaara I, Iwaa F, Cushner HM, Koolen M, Gainza FJ, Gitelman HJ, Lifton RP (1996a) Gitelman's variant of Bartter's syndrome, inherited hypokalaemic alkalosis, is caused by mutations in the thiazide-sensitive NaCl cotransporter. Nat Genet 12:24-30
228. Simon DB, Karet FE, Hamdan JM, diPietro A, Sanjad SA, Lifton RP (1996b) Bartter's syndrome, hypokalaemic alkalosis with hyperclaciuria, is caused by mutations in the Na-K-2Cl cotransporter NKCC2. Nat Genet 13:183-188
229. + channel ROMK. Nat Genet 14:152-156
230. Simon DB, Bindra RS, Mansfield TA, Nelson-Williams C, Mendonca E, Stone R, Schurman S, Nayir A, Alpay H, Bakkaloglu A, Rodriguez-Soriano J, Morales JM, Sanjad SA, Taylor CM, Pilz D, Brem A, Trachtman H, Griswold W, Richard GA, John E, Lifton RP (1997) Mutations in the chloride channel gene, CLCNKB, cause Bartter's syndrome type III. Nat Genet 17:171-178
231. Sinnarajah S, Dessauer CW, Srikumar D, Chen J, Yuen J, Yilma S, Dennis JC, Morrison EE, Vodyanoy V, Kehrl JH (2001) RGS2 regulates signal transduction in olfactory neurons by attenuating activation of adenylyl cyclase III. Nature 409:1051-1055
232. Sofowora GG, Dishy V, Muszkat M, Xie HG, Kim RB, Harris PA, Prasad HC, Byrne DW, Nair UB, Wood AJ, Stein CM (2003) A common β1-adrenergic receptor polymorphism (Arg389Gly) affects blood pressure response to β-blockade. Clin Pharmacol Ther 73:366-371
233. Speirs HJ, Morris BJ (2004) WNK4 intron 10 polymorphism is not associated with hypertension. Hypertension 43:766-768
234. Speirs HJL, Katyk K, Kumar NN, Benjafield AV, Wang WYS, Morris BJ (2004) Association of G-protein-coupled receptor kinase 4 haplotypes, but not HSD3B1 or PTP1B polymorphisms, with essential hypertension. J Hypertens 22:931-936
235. Speirs HJ, Wang WYS, Benjafield AV, Morris BJ (2005) No association with hypertension of CLCNKB and TNFRS1B polymorphism at a hypertension locus on chromosome 1p36. J Hypertens 23:1491-1496
236. Spiering W, Kroon AA, Fuss-Lejeune MM, Daemen MJ, de Leeuw PW (2000) Angiotensin II sensitivity is associated with the angiotensin II type 1 receptor A(1166)C polymorphism in essential hypertensives on a high sodium diet. Hypertension 36:411-416
237. Spiering W, Kroon AA, Fuss-Lejeune MM, de Leeuw PP (2005) Genetic contribution to the acute effects of angiotensin II type 1 receptor blockade. J Hypertens 23:753-758
238. Staessen JA, Wang JG, Ginocchio G, Petrov V, Saavedra AP, Soubrier F, Vlietinck R, Fagard R (1997) The deletion / insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk. J Hypertens 15:1579-1592
239. Staessen JA, Kuznetsova T, Wang JG, Emelianov D, Vlietnick R, Fagard R (1999) M235T angiotensinogen gene polymorphism and cardiovascular risk. J Hypertens 17:9-17
240. Staessen JA, Wang JG, Brand E, Barlassina C, Birkenhager WH, Herrmann SM, Fagard R, Tizzoni L, Bianchi G (2001) Effects of three candidate genes on prevalence and incidence of hypertension in a Caucasian population. J Hypertens 19:1349-1358
241. Staub O, Dho S, Henry P, Correa J, Ishikawa T, McGlade J, Rotin D (1996) WW domains of Nedd4 bind to the praline-rich PY motifs in the epithelial sodium channel deleted in Liddle's syndrome. EMBO J 15:2371-2380
242. Stavroulakis GA, Makris TK, Krespi PG, Hatzizacharias AN, Gialeraki AE, Anastasiadis G, Triposkiadis P, Kyriakidis M (2000) Predicting response to chronic antihypertensive treatment with fosinopril: the role of angiotensin-converting enzyme gene polymorphisms. Cardiovasc Drugs Ther 14:427-432
243. Stein CM, Nelson R, Deegan H, He H, Wood M, Wood AJ (1995) Forearm beta adrenergic receptor-mediated vasodilation is impaired, without alteration of forearm norepinephrine spillover, in borderline hypertension. J Clin Invest 96:579-585
244. Stewart PM, Wallace AM, Valentino R, Burt D, Shackleton CH, Edwards CR (1987) Mineralocorticoid activity of liquorice: 11-beta-hydroxysteroid dehydrogenase deficiency comes of age. Lancet 2:821-824
245. Strautnieks SS, Thompson RJ, Gardiner RM, Chung E (1996) A novel splice-site mutation in the γ subunit of the epithelial sodium channel gene in three pseudohypoaldosteronism type 1 families. Nat Genet 13:248-250
246. Subramanya AR, Yang CL, McCormick JA, Ellison DH (2006) WNK kinases regualte sodium chloride and potassium transport by the aldosterone-sensitive distal nephron. Kidney Int 70:630-634
247. Sutherland DJ, Ruse JL, Laidlaw JC (1966) Hypertension, increased aldosterone secretion and low plasma renin activity relieved by dexamethasone. Can Med Assoc J 95:1109-1119
248. + channel. Cell 83:969-978
249. Takahashi N, Smithies O (1999) Gene targeting approaches to analyzing hypertension. J Am Soc Nephrol 17:1598-1605
250. Takahashi N, Murakami H, Kodama K, Kasagi F, Yamada M, Nishishita T, Inagami T (2000) Association of a polymorphism at the 5'-region of the angiotensin II type 1 receptor with hypertension. Ann Hum Genet 64:197-205
251. Tang KM, Wang GR, Lu P, Karas RH, Aronovitz M, Heximer SP, Kaltenbronn KM, Blumer KJ, Siderovski DP, Zhu Y, Mendelsohn ME (2003) Regulator of G-protein signaling-2 mediates vascular smooth muscle relaxation and blood pressure. Nat Med 9:1506-1512
252. Thekkumkara TJ, Linas SL (2003) Evidence for involvement of 3′-untranslated region on determining angiotensin II receptor coupling specificity with G proteins. Biochem J 370:631-639
253. Thiel BA, Chakravarti A, Cooper RS, Luke A, Lewis S, Lynn A, Tiwari H, Schork NJ, Weder AB (2003) A genome-wide linkage analysis investigating the determination of blood pressure in whites and African Americans. Am J Hypertens 16:151-153
254. Tiago AD, Samani NJ, Candy GP, Brooksbank R, Libhaber EN, Sareli P, Woodiwiss AJ, Norton GR (2002) Angiotensinogen gene promoter region variant modifies body size-ambulatory blood pressure relations in hypertension. Circulation 106:1483-1487
255. Tikhonoff V, Kuznetsova T, Stolarz K, Bianchi G, Casiglia E, Kawecka-Jaszcz K, Nikitin Y, Tizzone L, Wang JG, Staessen JA (2003) β-Adducin polymorphisms, blood pressure, and sodium excretion in three European populations. Am J Hypertens 16:840-846
256. Timmermann B, Mo R, Luft FC, Gerdts E, Busjahn A, Omvik P, Li GH, Schuster H, Wienker TF, Hoehe MR, Lund-Johansen P (1998) Beta-2 adrenoceptor genetic variation is associated with genetic predisposition to essential hypertension. The Bergen Blood Pressure Study. Kidney Int 53:1455-1460
257. Tiret L, Blanc H, Ruidavets JB, Arveiler D, Luc G, Jeunemaitre X, Tichet J, Mallet C, Poirier O, Plouin PF, Cambien F (1998) Gene polymorphisms of the renin-angiotensin system in relation to hypertension and parental history of myocardial infarction and stroke: the PEGASE study. J Hypertens 16:37-44
258. Tobin MD, Raleigh SM, Newhouse S, Braund P, Bodycote C, Ogleby J, Cross D, Gracey J, Hayes S, Smith T, Ridge C, Caulfield M, Sheehan NA, Munroe PB, Burton PR, Samani NJ (2005) Association of WNK1 gene polymorphisms and haplotypes with ambulatory blood pressure in the general population. Circulation 112:3423-3429
259. Toka HR, Bähring S, Chitayat D, Melby JC, Whitehead R, Jeschke R, Wienker TF, Toka O, Schuster H, Luft FC (1998) Families with autosomal-dominant brachydactyly type E, short stature, and severe hypertension. Ann Intern Med 129:204-208
260. Tripodi MG, Valtorta F, Torielli L, Chieregatti E, Salardi S, Trusolino L, Menegon A, Ferrari P, Marchisio PC, Bianchi G (1996) Hypertension associated point mutations in the adducin α and β subunits affect actin cytoskeleton and ion transport. J Clin Invest 97:2815-2822
261. Tripodi MG, Szpirer C, Reina C, Szpirer J, Bianchi G (1997) Polymorphism of γ-adducin gene in genetic hypertension and mapping of the gene to rat chromosome 1q55. Biochem Biophys Res Comm 237:685-689
262. Tripodi MG, Florio M, Ferrandi M, Modica R, Zimdahl H, Hubner N, Ferrari P, Bianchi G (2004) Effect of Add1 gene transfer on blood pressure in reciprocal congenic strains of Milan rats. Biochem Biophys Res Comm 324:562-568
263. Tsai CT, Fallin D, Chiang FT, Hwang JJ, Lai LP, Hsu KL, Tseng CD, Liau CS, Tseng YZ (2003) Angiotensionogen gene haplotype and hypertension:interaction with ACE gene I allele. Hypertension 41:9-15
264. Turner ST, Boerwinkle E (2003) Genetics of blood pressure, hypertensive complications, and antihypertensive drug responses. Pharmacogenomics 4:53-65
265. Turner ST, Schwartz GL, Chapman AB, Boerwinkle E (2001a) C825T polymorphism of the G protein β3 subunit and antihypertensive response to a thiazide diuretic. Hypertension 37:739-743
266. Turner ST, Schwartz GL, Chapman AB, Hall WD, Boerwinkle E (2001b) Antihypertensive pharmacogenetics: getting the right drug into the right patient. J Hypertens 19:1-11
267. Turner ST, Chapman AB, Schwartz GL, Boerwinkle E (2003) Effects of endothelial nitric oxide synthase, α-adducin, and other candidate gene polymorphisms on blood pressure response to hydrochlorothiazide. Am J Hypertens 16:834-839
268. Ueda S, Meredith PA, Morton JJ, Connell JMC, Elliot HL (1998) ACE (I/D) genotype is a predictor of the magnitude and duration of the response to an ACE inhibitor drug (enalaprilat) in humans. Circulation 98:2148-2153
269. Vasku A, Soucek M, Znojil V, Rihacek I, Tschoplova S, Strelcova L, Chidl K, Blakova M, Hajek D, Holla L, Vacha J (1998) Angiotensin I-converting enzyme and angiotensinogen gene interaction and prediction of essential hypertension. Kidney Int 53:1479-1482
270. Villard E, Tiret L, Visvikis S, Rakotovao R, Cambien F, Soubrier F (1996) Identification of new polymorphisms of the angiotensin I-converting enzyme (ACE) gene, and study of their relationship to plasma ACE levels by two QTL segregation-linkage anlysis. Am J Hum Genet 58:1268-1278
271. Wallace C, Xue MZ, Newhouse SJ, Marcano AC, Onipinla AK, Burke B, Gungadoo J, Dobson RJ, Brown M, Connell JM, Dominiczak A, Lathrop GM, Webster J, Farrall M, Mein C, Samani NJ, Caulfield MJ, Clayton DG, Munroe PB (2006) Linkage analysis using co-phenotypes in the BRIGHT study reveals novel potential susceptibility loci for hypertension. Am J Hum Genet 79:323-331
272. Wang WYS, Zee RYL, Moris BJ (1997) Association of angiotensin II type I receptor gene polymorphism with essential hypertension. Clin Genet 51:31-34
273. Wang J, Mougey EB, David CJ, Humma LM, Johnson JA, Lima JJ, Sylvester JE (2001) Determination of human beta(2)adrenoceptor haplotypes by denaturation selective amplification and subtractive genotyping. Am J Pharmacogenomics 1:315-322
274. Wang JG, Liu L, Zagato L, Xie J, Fagard R, Jin K, Wang J, Li Y, Bianchi G, Staessen JA, Liu L (2004) Blood pressure in relation to three candidate genes in a Chinese population. J Hypertens 22:937-944
275. 2+ signalling by binding the N-terminal domain of RGS2 and the third intracellular loop of G-protein-coupled receptors. Nature Cell Biol 7:405-411
276. Ward K, Hata A, Jeunemaitre X, Helin C, Nelson L, Namikawa C, Farrington PF, Ogasawara M, Suzumori K, Tomoda S, Berrebi S, Sasaki M, Corvol P, Lifton RP, Lalouel J-M (1992) A molecular variant of angiotensiogen associated with preeclampsia. Nat Genet 4:59-61
277. Weinstein LS, Chen M, Xie T, Liu J (2006) Genetic diseases associated with heterotrimeric G proteins. Trends Pharmacol Sci 27:260-266
278. Wenzel RR, Siffert W, Bruck H, Philipp T, Schäfers RF (2002) Enhanced vasoconstriction to endothelin-1, angiotensin II and noradrenaline in carriers of the GNB3 825T allele in the skin microcirculation. Pharmacogenetics 12:489-495
279. Wettschureck N, Offermanns S (2005) Mammalian G proteins and their cell type specific functions. Physiol Rev 85:1159-1204
280. White PC, Dupont J, New MI, Leiberman E, Hochberg Z, Rosier A (1991) A mutation in CYP11B1 (arg488 to his) associated with 11-beta-hydroxylase deficiency in Jews of Moroccan origin. J Clin Invest 87:1664-1667
281. Wieland T, Mittmann C (2003) Regulators of G-protein signalling: multifunctional proteins with impact on signalling in the cardiovascular system. Pharmacol Ther 97:95-115
282. Wilson RC, Dave-Sharma S, Wei JQ, Obeyesekere VR, Li K, Ferrari P, Krozowski ZS, Shackleton CHL, Bradlow L, Wiens T, New MI (1998) A genetic defect resulting in mild low-renin hypertension. Proc Natl Acad Sci USA 95:10200-10205
283. Wilson FH, Disse-Nicodeme S, Choate KA, Ishikawa K, Nelson-Williams C, Disitter I, Gunel M, Milford DV, Lipkin GW, Achard JM, Freely MP, Dussol B, Berland Y, Unwin RJ, Mayan H, Simon DB, Farfel Z, Jeunemaitre X, Lifton RP (2001) Human hypertension caused by mutations in WNK kinases. Science 293:1107-1112
284. Wilson FH, Kahle KT, Sabath E, Lalioti MD, Rapson AK, Hoover RS, Hebert SC, Gamba G, Lifton RP (2003) Molecular pathogenesis of inherited hypertension with hyperkalemia: the Na-Cl cotransporter is inhibited by wild-type but not mutated WNK4. Proc Natl Acad Sci USA 100:680-684
285. Wolf-Maier K, Cooper RS, Kramer H, Banegas JR, Giampaoli S, Joffres MR, Poulter N, Primatesta P, Stegmayr B, Thamm M (2004) Hypertension Treatment and Control in Five European Countries, Canada, and the United States. Hypertension 43:10-17
286. Wyckoff JA, Seely EW, Hurwitz S, Anderson BF, Lifton RP, Dluhy RG (2000) Glucocorticoid-remediable aldosteronism and pregnancy. Hypertension 31:445-450
287. Xie HG, Stein CM, Kim RB, Gainer JV, Sofowora G, Dishy V, Brown NJ, Goree RE, Haines JL, Wood AJ (2000) Human beta2-adrenergic receptor polymorphisms: no association with essential hypertension in black or white Americans. Clin Pharmacol Ther 67:670-675
288. Yamamoto M, Abe M, Jin JJ, Wu Z, Tabara Y, Mogi M, Kohara K, Miki T, Nakura J (2004) Association of a GNAS1 gene variant with hypertension and diabetes mellitus. Hypertes Res 27:919-924
289. Yang CL, Angell J, Mitchell R, Ellison DH (2003) WNK kinases regulate thiazide-sensitive Na-Cl cotransport. J Clin Invest 111:1039-1045
290. +-ATPase a subunit and regulates its trafficking. Proc Natl Acad Sci USA 97:6556-6561
291. Zee RY, Ridker PM, Stampfer MJ, Hennekens CH, Lindpaintner K (1999) Prospective evaluation of the angiotensin-converting enzyme insertion/deletion polymorphism and the risk of stroke. Circulation 99:340-343
292. Zeltner R, Delles C, Schneider M, Siffert W, Schmieder RE (2001) Gprotein beta(3) subunit gene (GNB3) 825T allele is associated with enhanced renal perfusion in early hypertension. Hypertension 37:882-886
293. Zeng C, Sanada H, Watanabe H, Eisner GM, Felder RA, Jose PA (2004) Functional genomics of the dopaminergic system in hypertension. Physiol Genomics 199:233-246
294. Zhang X, Erdmann J, Regitz-Zagrosek V, Kürzinger S, Hense HW, Schunkert H (2000) Evaluation of three polymorphisms in the promoter region of the angiotensin II type I receptor gene. J Hypertens 18:267-272
295. Zhao YY, Zhou J, Narayanan CS, Cui Y, Kumar A (1999) Role of C/A polymorphism at -20 on the expression of human angiotensinogen gene. Hypertension 33:108-115
296. Zhu X, McKenzie CA, Forrester T, Nickerson DA, Broeckel U, Schunkert H, Doering A, Jacob HJ, Cooper RS, Rieder MJ (2000) Localization of a small genomic region associated with elevated ACE. Am J Hum Genet 67:1144-1153
297. Zhu X, Chang YP, Yan D, Weder A, Cooper R, Luke A, Kan D, Chakravarti A (2003a) Associations between hypertension and genes in the renin-angiotensin system. Hypertension 41:1027-1034
298. Zhu X, Yan D, Cooper RS, Luke A, Ikeda MA, Chang YP, Weder A, Chakravarti A (2003b) Linkage disequilibrium and haplotype diversity in the genes of the renin-angiotensin system: findings from the family blood pressure program. Genome Res 13:173-181